Journal of Clinical Endocrinology & Metabolism, Vol 66, 1014-1018, Copyright © 1988 by Endocrine Society

ARTICLES

Free insulin-like growth factor I (IGF-I) and IGF-II in human saliva

DC Costigan, HJ Guyda and BI Posner
Division of Endocrinology and Metabolism, Montreal Children's Hospital- Research Institute, Quebec, Canada.

We found that human saliva contains both insulin-like growth factor I (IGF-I) and IGF-II but no significant binding proteins, and that salivary IGF-I levels correlated with plasma GH levels. Mixed saliva had globular proteins precipitated by freezing/thawing. After centrifugation the clear supernatant was used directly in the IGF-I RIA (Van Wyk and Underwood antibody) and in a human placental membrane RRA for IGF-II. The lower limits of detection for IGF-I and IGF-II were 0.7 ng/mL (micrograms/L) and 1.2 ng/mL (micrograms/L), respectively. Iodinated IGF added to saliva was not degraded, as assessed by trichloroacetic acid precipitability and placental membrane binding. In saliva from 14 normal subjects, IGF-I was measurable in all. IGF-II was detectable only in 8 of 14 subjects; the mean value in these 8 subjects was 2.6 +/- 0.6 (+/- SE) ng/mL (micrograms/L). The mol wt of salivary IGF was similar to that of free plasma IGF after acid or neutral pH gel chromatography. Human saliva contained no significant IGF-binding protein. Eluates from neutral gel chromatography of concentrated (20- fold) normal saliva did not inhibit IGF-II binding to placental membrane receptors. Eluted proteins from saliva samples subjected to prior acid gel chromatography failed to bind radiolabeled IGF after neutralization. Saliva samples assayed for binding protein using an amniotic fluid binding protein RIA had values at or below the lower limit of detection [less than 0.06 micrograms eq/mL (mgeq/L)]. Salivary IGF-I concentrations did not change with increasing salivary flow rates above normal, with time of day, or with storage at room temperature for up to 24 h before freezing. The mean IGF-I concentration in mixed saliva from 14 normal young adults (8 men) was 2.3 +/- 0.3 (+/- SE) ng/mL (micrograms/L), and their mean plasma IGF-I level was 315 +/- 27 ng/mL (micrograms/L). Mean salivary IGF-I was significantly lower in 15 patients with GH deficiency [1.3 +/- 0.2 ng/mL (micrograms/L); P less than 0.01] and 8-fold higher in 5 acromegalic patients [17.2 +/- 6.3 ng/mL (micrograms/L); P less 0.01]. Removal of their GH adenomas led to a fall in salivary IGF-I to 5.6 +/- 1.3 ng/mL (micrograms/L); P less than 0.05). In summary, saliva contains free IGFs but no significant quantities of specific binding proteins. Salivary IGF-I levels reflect the GH status of the donor.

This article has been cited by other articles:

				A. Imsumran, Y. Adachi, H. Yamamoto, R. Li, Y. Wang, Y. Min, W. Piao, K. Nosho, Y. Arimura, Y. Shinomura, et al. Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma Carcinogenesis, May 1, 2007; 28(5): 947 - 956. [Abstract] [Full Text] [PDF]

				C. E. Commare and K. A. Tappenden Development of the Infant Intestine: Implications for Nutrition Support Nutr Clin Pract, April 1, 2007; 22(2): 159 - 173. [Abstract] [Full Text] [PDF]

				T. Nguyen, J. Chai, A. Li, T. Akahoshi, T. Tanigawa, and A. S. Tarnawski Novel Roles of Local Insulin-Like Growth Factor-1 Activation in Gastric Ulcer Healing: Promotes Actin Polymerization, Cell Proliferation, Re-Epithelialization, and Induces Cyclooxygenase-2 in a Phosphatidylinositol 3-Kinase-Dependent Manner Am. J. Pathol., April 1, 2007; 170(4): 1219 - 1228. [Abstract] [Full Text] [PDF]

				N. Abe, T. Matsunaga, K. Kameda, H. Tomita, T. Fujiwara, H. Ishizaka, H. Hanada, K. Fukui, I. Fukuda, T. Osanai, et al. Increased Level of Pericardial Insulin-Like Growth Factor-1 in Patients With Left Ventricular Dysfunction and Advanced Heart Failure J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1387 - 1395. [Abstract] [Full Text] [PDF]

				H. Werner and J. Katz The Emerging Role of the Insulin-like Growth Factors in Oral Biology J. Dent. Res., November 1, 2004; 83(11): 832 - 836. [Abstract] [Full Text] [PDF]

				O. E. Sorensen, J. B. Cowland, K. Theilgaard-Monch, L. Liu, T. Ganz, and N. Borregaard Wound Healing and Expression of Antimicrobial Peptides/Polypeptides in Human Keratinocytes, a Consequence of Common Growth Factors J. Immunol., June 1, 2003; 170(11): 5583 - 5589. [Abstract] [Full Text] [PDF]

				A. Nagy, H. Nagashima, S. Cha, G. E. Oxford, T. Zelles, A. B. Peck, and M. G. Humphreys-Beher Reduced Oral Wound Healing in the NOD Mouse Model for Type 1 Autoimmune Diabetes and Its Reversal by Epidermal Growth Factor Supplementation Diabetes, September 1, 2001; 50(9): 2100 - 2104. [Abstract] [Full Text] [PDF]

				A. Juul, K. Holm, K. W. Kastrup, S. A. Pedersen, K. F. Michaelsen, T. Scheike, S. Rasmussen, J. Muller, and N. E. Skakkebak Free Insulin-Like Growth Factor I Serum Levels in 1430 Healthy Children and Adults, and Its Diagnostic Value in Patients Suspected of Growth Hormone Deficiency J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2497 - 2502. [Abstract] [Full Text] [PDF]

				D. G. Burrin Is Milk-Borne Insulin-Like Growth Factor-I Essential for Neonatal Development? J. Nutr., May 1, 1997; 127 (5): 975S - 975S. [Abstract] [Full Text] [PDF]